Press Releases

Manhattan Scientifics Reaches the Fork (Falk) in the Road

(August 20, 2014) ALBUQUERQUE, N.M.--Spencer Falk, whose marketing expertise was mission-critical to the blockbuster success of Viagra and Celebrex, among other medical brands, today announced that he would lead the commercialization of early cancer detection technology for Senior Scientific, a division of Manhattan Scientifics. Full release

Pushing the Limits of Cancer Detection

(June 10, 2014) ALBUQUERQUE, N.M.-- Manhattan Scientifics, Inc. (OTCQB: MHTX) announced today that it has delivered its break-through, cancer measurement instrument to The University of Texas M.D. Anderson Cancer Center in Houston, TX. Full release

PrecisionMRX™ Nanoparticle Production Process Ready

(April 14, 2014) Building upon local relationships, Senior Scientific is stepping into the commercial space with first product introductions through Azano Biotech. Azano currently supplies research reagents to the same cancer researchers who will eventually be customers for the MRX II instrument. Full release

Progress on our First Major Product: the NanoMRX™ II

(March 19, 2014) The overarching mission for February has been to get the 9 Channel System up and running. We are delighted to be delivering this extraordinary device to our collaborators at MD Anderson. Full release

Manhattan Scientifics Announces Commercial Introduction Of NanoMRX Precision Nanoparticles

(March 18, 2014) ALBUQUERQUE, N.M. -- Manhattan Scientifics (OTCQB: MHTX) announced today a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase. Full release

MHTX Announces Collaboration with MD Anderson Cancer Center

(January 27, 2014) ALBUQUERQUE, N.M.--Manhattan Scientifics (OTC: MHTX) executed an agreement to collaborate with The University of Texas MD Anderson Cancer Center (MDACC) to advance, demonstrate and validate a breakthrough technology developed by Edward R. Flynn, PhD, for the very early detection of cancer. Dr. Flynn is the founder and chief scientist of MHTX’s subsidiary, Senior Scientific LLC. Senior Scientific is seeking to commercialize this patented non-invasive technology using ultra-sensitive magnetic detectors to locate, identify and measure tumors thousands of times smaller than detectable using current technologies. Full release

MHTX Announces Initiation of Coverage by Independent Equity Research Firm SeeThruEquity, LLC

(October 1, 2013) New York, NY – Manhattan Scientifics Inc. (OTCQB: MHTX) announced today that SeeThruEquity, LLC has initiated coverage on the Company. The report is now available for viewing at the following link.  Full release

MHTX Announces the Engagement of Loraine Upham to Market Its Cancer Diagnostic Technology

(August 23, 2013) Manhattan Scientifics announced today that Loraine Upham has been engaged as a consultant to support its cancer team. The technology, developed by Edward R. Flynn, PhD, provides the most specific and most sensitive method for detecting cancer currently known. Full release

Senior Scientific Announces Issuance of U.S. Patent

(May 23, 2013) Senior Scientific, LLC, a unit of Manhattan Scientifics and a developer of molecular imaging and nanobiotechnology for the early detection and localization of cancer and other human diseases, today announced that the United States Patent Office (USPTO) has issued U.S. Patent No. 8,447,379 entitled "Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof." Full release

Manhattan Scientifics Announces Receipt of $2.5M Commitment to Build Breakthrough Cancer Detection

(April 9, 2013) NEW YORK--Manhattan Scientifics announced today that it has received the initial $1 million of a $2.5 million commitment to build the first generation of its advanced cancer detection devices. Full release

Interview with mobile phone inventor Marty Cooper

(April 3, 2013) The first mobile phone call was made 40 years ago today, on 3 April 1973. Martin Cooper, at the time a senior engineer at Motorola and now a member of our Science and Technology Committee, called a rival colleague at another telecoms company and announced he was speaking from "a 'real' cell telephone". Full release

Cancer Research: NFCR Cites MHTX’s Early Cancer Detection Tech as Research Breakthrough for 2012

(January 7, 2013) ALBUQUERQUE, N.M.--The National Foundation for Cancer Research (NFCR) has listed the SQUID-based cancer imaging technology developed by MHTX's (OTCBB: MHTX) Senior Scientific subsidiary as a "2012 Research Breakthrough." Full release

MHTX Achieves Significant Milestones in Pursuit of its Early Cancer Detection & Treatment Technology

(August 13, 2012) ALBUQUERQUE, N.M.--Manhattan Scientifics (OTCBB:MHTX) announced today that it has achieved several critical milestones in the development of its proprietary technology for the early detection and treatment of cancer. Full release

National Foundation For Cancer Research Funds Novel Approach To Early Detection Of Ovarian Cancer

(February 23, 2012) ALBUQUERQUE, N.M.--The National Foundation for Cancer Research has awarded a grant to Dr. Robert C. Bast, Jr. of The University of Texas MD Anderson Cancer Center to work with Senior Scientific LLC, a company owned by Manhattan Scientifics (OTCBB: MHTX), to apply Senior Scientifics’ technology to the early detection of ovarian cancer. Full release

Fortune: Manhattan Scientifics Is A Leader In The Race For A Better Mammogram

(December 19, 2011) NEW YORK--"The race is on for a better mammogram" states the December 19th headline in Fortune Magazine's (online) story by Sierra Jiminez. The story then begins—and ends—with the breakthrough work of Edward R. Flynn, PhD, of Manhattan Scientifics Inc. Full release

Manhattan Scientifics CEO Issues Letter To Shareholders

(December 15, 2011) Thank you for your investment in Manhattan Scientifics. I want to personally and corporately thank all our shareholders for their encouragement. I sincerely believe that 2012 is going to be a break-out year for Manhattan Scientifics. Full release

“Breast Cancer Research” Publishes Key Study; Cancer-Sensing Technology Is Radiation-Free

(October 31, 2011) ALBUQUERQUE, N.M.--Manhattan Scientifics (OTCBB: MHTX) announced today that “Breast Cancer Research,” an international, peer-reviewed online journal, has published results of a study using Senior Scientific’s nanomagnetic technology. Full release

Watching Cancer Cells Disappear During Therapy

(October 13, 2011) ALBUQUERQUE, N.M.--Manhattan Scientifics (OTCBB: MHTX) announced today that the National Cancer Institute (NCI) has funded a grant for its Senior Scientific, LLC unit, for the use of its proprietary, highly precise magnetic cancer cell measurement in leukemia research for determining the progress of cancer treatment. Full release

Dr. Edward Flynn Recognized In American Physics Society Journal For His Work In Cancer Detection

(October 4, 2011) ALBUQUERQUE, N.M.--Dr. Edward R. Flynn Ph.D., founder of Senior Scientific, LLC, a company owned by Manhattan Scientifics (OTCBB:MHTX), has been prominently mentioned in the October issue of The America Physics Society Journal for his work in cancer detection. Full release

Profiles In Versatility

(October 1, 2011) A cabal of cacophonic college kids inspired Shahriar Afshar to become an entrepreneur. It was 2004, and the physicist was serving as a visiting professor at a college, temporarily residing in the dorms. "It was summer, and the kids loved playing video games and listen[ing] to loud music, which shook the whole building. Full release

Breast Cancer: How Far Have We Come?

(October 1, 2011) An easy at-home test? Drugs that slash your risk? These aren’t science fiction -- they’re real advances that are revolutionizing the way we find, treat and defeat this disease. Every October, we don pink ribbons, buy pink-hued products and support charity runs with pink logos. Has it made a difference? You bet. Full release

Manhattan Scientifics Names V. Gerald Grafe To Commercialize Senior Scientific

(August 2, 2011) ALBUQUERQUE, N.M.--Manhattan Scientifics (OTCBB: MHTX) today announced it has named V. Gerald Grafe to lead the commercialization of Senior Scientific. Full release

Manhattan Scientifics Acquires Senior Scientific To Speed Applications Of Early Cancer Detection

(June 6, 2011) ALBUQUERQUE, N.M.--In a move to accelerate applications of a novel cancer detection and treatment technology, Manhattan Scientifics (OTCBB: MHTX) today announced that it has acquired all of Senior Scientific, LLC and its affiliate Scientific Nanomedicine Inc. Primarily developed by Edward R. Flynn, Ph.D Full release

Manhattan Scientifics Triples Revenue

(April 4, 2011) NEW YORK--Manhattan Scientifics, Inc. (OTCBB: MHTX) today announced its results of operations for the year ended December 31, 2010. The company announced that it tripled its revenue in year 2010 and reduced its loss to $43,000 from a loss of $446,000 in year 2009. Full release

Past Releases